Texas

The growth of fibril tips is thought to be the ‘Achilles’ heel’ of the process.

There were a fair number of clinical trial announcements last week. Here’s a look.

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

BioLabs is opening its next hub in Dallas in a 37,000-square-foot flexible life science facility. The Biotech+ Hub can accommodate 35 startups, for which it’s now accepting applications.

Research seems to concur that a person who has recovered from severe COVID-19 symptoms might experience cognitive function and memory loss later on.

The United States and other wealthy nations now stand at an important place in their COVID-19 vaccine campaigns. The question largely turns to vaccinating the remainder of the population – namely, those under 12 years.

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

The research will focus on accelerating the capacities of BLU-222, an investigational therapy that Blueprint designed to target cyclin-dependent kinase 2 (CDK2).

There has been a flurry of expansion activity in the life sciences industry as biopharma and diagnostic companies expand manufacturing sites. Here’s a look.

Just as it was beginning to appear safe to return to maskless, pre-pandemic life, the Delta variant of the SARS-CoV-2 virus emerged. It is fast-spreading, more likely to lead to hospitalizations, and accounts for most of the breakout infections among fully vaccinated individuals.